142
Views
4
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Digital PET and detection of recurrent prostate cancer: what have we gained, and what is still missing?

ORCID Icon & ORCID Icon
Pages 1107-1110 | Received 21 Jun 2021, Accepted 04 Oct 2021, Published online: 13 Oct 2021

References

  • Alberts I, J-n H, Sachpekidis C, et al. The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer. Eur Radiol. 2021;31:8030–8039.
  • Filippi L, Chiaravalloti A, Schillaci O, et al. Theranostic approaches in nuclear medicine: current status and future prospects. Expert Rev Med Devices. 2020;17:331–343.
  • Carlucci G, Ippisch R, Slavik R, et al. 68Ga-PSMA-11 NDA approval: a novel and successful academic partnership. J Nucl Med. 2021;62:149–155.
  • Calais J, Czernin J, Cao M, et al. 68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage radiotherapy planning. J Nucl Med. 2018;59:230–237.
  • Wright CL, Binzel K, Zhang J, et al. Advanced functional tumor imaging and precision nuclear medicine enabled by digital PET technologies. Contrast Media Mol Imaging. 2017;2017:5260305.
  • D’Ascenzo N, Xie Q. Plug silicon photomultiplier for the & imaging PET system: physics, technological challenges and application to modern nuclear medicine. In: Britun N, Nikiforov A, editors. Photon counting - fundamentals and applications; London (UK): IntechOpen. 2018. DOI:https://doi.org/10.5772/intechopen.73007.
  • Delcroix O, Bourhis D, Keromnes N, et al. Assessment of image quality and lesion detectability with digital PET/CT system. Front Med (Lausanne). 2021;8:629096.
  • Rowe SP, Pienta KJ, Pomper MG, et al. PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA–targeted PET imaging studies. Eur Urol. 2018;73(4):485–487.
  • Alberts I, Prenosil G, Sachpekidis C, et al. Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison. Eur J Nucl Med Mol Imaging. 2020;47:614–623.
  • Koopman D, van Dalen JA, Stevens H, et al. Performance of digital PET compared with high-resolution conventional PET in patients with cancer. J Nucl Med. 2020;61:1448–1454.
  • Jonmarker O, Axelsson R, Nilsson T, et al. Comparison of regularized reconstruction and ordered subset expectation maximization reconstruction in the diagnostics of prostate cancer using digital time-of-flight 68Ga-PSMA-11 PET/CT imaging. Diagnostics (Basel). 2021;11:630.
  • Wondergem M, Jansen BHE, van der Zant FM, et al. Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2019;46:1911–1918.
  • Ferraro DA, Rüschoff JH, Muehlematter UJ, et al. Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68Ga-PSMA-11-PET. Theranostics. 2020;10:6082–6094.
  • Alberts I, Sachpekidis C, Fech V, et al. PSMA-negative prostate cancer and the continued value of choline-PET/CT. Nuklearmedizin. 2020;59:33–34.
  • Bin X, Yong S, Kong Q-F, et al. Diagnostic performance of PET/CT using 18F-FACBC in prostate cancer: a meta-analysis. Front Oncol. 2019;9:1438.
  • Lindström E, Lindsjö L, Sundin A, et al. Evaluation of block-sequential regularized expectation maximization reconstruction of 68Ga-DOTATOC, 18F-fluoride, and 11C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner. EJNMMI Phys. 2020 Jun 15;7:40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.